MITCHELL DEAN J

CIK 000119929711 companiesRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001199297

Recent Transactions

50 trades

Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2025-09-24−1,753→ 8,767 total
Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2025-09-24−1,932→ 0 total
Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2025-09-24$14.36/sh+1,932→ 6,932 total
Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2025-09-24−8,566→ 0 total
Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2025-09-24$44.25/sh+8,566→ 15,498 total
Exercise/Conversion
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2025-09-24$44.04/sh+1,753→ 17,251 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2025-06-26+10,520→ 10,520 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2025-05-19+10,649→ 91,204 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2024-06-05+8,566→ 8,566 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2024-05-08+10,537→ 80,555 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−121,503→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−25,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-03-14+87,412→ 87,412 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2024-03-14+101,626→ 101,626 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2024-03-14$1.43/sh+39,510→ 503,183 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2024-03-09+106,837→ 463,673 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-03-09−106,837→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Common Stock
2024-02-12−103,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Deferred Share Unit
2024-02-12−142,667→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−13,090→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−18,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−10,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−10,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−19,597→ 0 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-09-22−10,000→ 0 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-09-22$14.70/sh+10,000→ 103,000 total
Purchase
PRECIGEN, INC.$PGEN
Common Stock
2023-09-22$1.41/sh+25,000→ 356,836 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-09-22$14.70/sh+10,000→ 152,667 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-06-14+13,090→ 13,090 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-06-14+19,597→ 19,597 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2023-06-12+28,981→ 28,981 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2023-06-12+25,000→ 25,000 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-05-02+22,044→ 22,044 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-05-02+9,132→ 70,018 total
Purchase
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2023-03-24$0.84/sh+50,000→ 75,000 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-03-09+106,837→ 106,837 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2023-03-09$1.17/sh+48,290→ 331,836 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2023-03-09+125,489→ 125,489 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-02-22−61,576→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-02-22+61,576→ 283,546 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-12-30+3,024→ 142,667 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-09-30+3,138→ 139,643 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-30+3,333→ 136,505 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-15+15,000→ 133,172 total

Companies

Recent Filings

Address

C/O TALECRIS BIOTHERAPEUTICS HOLDINGS P.O. BOX 110526 4101 RESEARCH COMMONS

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov